Analysis of Factors Influencing the Efficacy of Levamlodipine Benzoate and Its Population Pharmacodynamic Modeling

Launched by THE SECOND AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY · Jul 20, 2023

Keywords

ClinConnect Summary

This clinical trial is looking at how well the medication levamlodipine besylate works for patients with high blood pressure, also known as hypertension. The researchers want to understand what factors might affect how effective this treatment is for different people. They will study things like age, medical history, other medications taken, and certain lab test results to see how these factors influence the results of the treatment. The goal is to create a better understanding of how to personalize treatment for each patient, ensuring that everyone gets the most suitable care.

To be part of this trial, participants must be newly diagnosed with high blood pressure and starting treatment with levamlodipine besylate. They can be of any age and gender. However, those who have previously taken other high blood pressure medications or who are unable to attend follow-up visits will not qualify. Participants can expect to have regular check-ups to monitor their blood pressure and health throughout the study, helping researchers gather important information that could lead to improved treatment options for hypertension in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Newly diagnosed patients with hypertension in our hospital (sex, age is not limited).
• • 2. Patients whose initial treatment is levamlodipine besylate.
• Exclusion Criteria:
• • 1. Patients who cannot be followed up regularly or are lost to follow-up after initial diagnosis and treatment.
• • 2. Patients who were initially treated with other antihypertensive drugs.
• • 3. Blood pressure was not measured when the patient came to the hospital for follow-up.